Lahalak Medical PlatformDifferentiate Care

Medical Laboratories

Non-Invasive Prenatal Test (NIPT)

Non-Invasive Prenatal Testing (NIPT)

A safe and highly accurate blood test to screen for fetal genetic abnormalities early in pregnancy, providing peace of mind for expecting parents from home.

Trusted medical contentUpdated: 25-04-2026Views: 117LHL-10

View service availability

Non-Invasive Prenatal Test (NIPT) | Non-Invasive Prenatal Testing (NIPT)

Home Service Available

Service typeLaboratory Test (Blood)

Duration10-15 minutes

Fasting / preparationFasting is not required

Home serviceAvailable

Medical notice: this information is for education and service understanding. It is not a diagnosis or a recommendation for an unnecessary procedure.

About this service

NIPT or Non-Invasive Prenatal Testing is a test performed during pregnancy to detect certain genetic abnormalities in the fetus early. This test is considered non-invasive because it relies on a blood sample from the mother rather than directly sampling amniotic fluid or fetal cells.

What does it detect?

Down syndrome (Trisomy 21).
Edwards syndrome (Trisomy 18).
Patau syndrome (Trisomy 13).
Some disorders related to the sex chromosomes (X and Y).

Features:

Non-invasive It is done by taking a sample from the mother's blood, making it safer compared to surgical tests.
Accurate Results It is characterized by an accuracy of up to 99% in detecting certain genetic abnormalities, especially Down syndrome.
Done Early It can be performed early in pregnancy, typically starting from the 10th week.

Recommended for:

Women at increased risk of genetic disorders due to age (35 years or older).
Women with a family history of genetic abnormalities.
Women who have had abnormal results in routine pregnancy tests.

Optimal timing:

Typically between the 10th and 13th weeks of pregnancy. It can be performed early in pregnancy to help parents obtain accurate information about the health of the fetus, especially regarding the detection of certain genetic abnormalities like Down syndrome.
This test is done using a simple blood sample from the mother, and it is recommended to be done during this early period to ensure accurate results and provide time for making necessary decisions based on the outcomes.

Preparations:

No special preparation is required. It does not require fasting or any specific preparations before the test.
It is always recommended to consult a specialist doctor before undergoing the test to obtain detailed information and ensure that the test is appropriate for your condition and pregnancy circumstances.

Steps:

Purchase the service by selecting the appropriate provider below. Our medical team will contact you and may ask you to provide the necessary information about the patient's health and the address where the sample will be collected.
Follow-up on the results: After the test is done, the medical team will review and analyze the results.
Sending medical reports: The medical reports will be sent to you.
Consulting with the doctor: Based on the results, the doctor may contact the patient or family to discuss the results and possible medical recommendations.

What is included?

✓Nurse visit for blood sample collection with results provided within 24 hours.
✓The optimal health guidance based on the result.
✓Personal support services from Lahalak

Conditions and notices

Fasting is not required
The terms and conditions announced on the "Lahalak" medical platform apply.
There are no special conditions for the service other than those mentioned.

Frequently Asked Questions

Short answers to the FAQs published with this service.

Is the genetic test safe for the mother and the fetus?

Yes, the non-invasive genetic test is completely safe for both the mother and the fetus. It only requires a blood sample from the mother and does not affect the pregnancy in any way.

When will I get the results?

The results are usually ready within 5 to 10 business days, and they will be sent to you via email or through direct communication.

Can the results be trusted?

The genetic test (NIPT) is highly accurate, with an accuracy rate of up to 99% for detecting certain genetic abnormalities, and it is highly reliable in assessing pregnancy-related risks.

Does the test cover all genetic disorders?

The genetic test (NIPT) covers some of the most common genetic disorders such as Down syndrome and Edwards syndrome. If you need more detailed tests, you can talk to your doctor to discuss additional tests.

What is the cost of the at-home genetic test?

Does it include the medical team's visit fees? The cost of the test varies based on the package and services required. It includes the test fees and the fees for the medical team’s visit to take the sample. We provide you with a comprehensive breakdown of the costs.

Is support provided if the results are abnormal?

Yes, we offer full support in case the results are abnormal. Specialized medical consultations will be provided to help you understand the results and take the appropriate steps.

How is the confidentiality of the results maintained?

We adhere to the highest standards of confidentiality. The test results are securely stored and are only sent to you through trusted channels.

Service resources and references

References and additional resources

Reference material and files associated with this service when available.

Scientific references

Bianchi, D. W., Parker, R. L., Wentworth, J., et al. (2014). DNA sequencing versus standard prenatal aneuploidy screening. New England Journal of Medicine, 370(9), 799–808. Landmark study showing that NIPT has higher sensitivity and specificity for detecting common trisomies (e.g., Down, Edwards, Patau) compared with traditional screening.
Norton, M. E., Jacobsson, B., Swamy, G. K., et al. (2015). Cell‑free DNA analysis for noninvasive prenatal screening. New England Journal of Medicine, 372(17), 1589–1597. Demonstrates that NIPT using cell‑free fetal DNA in maternal blood provides high accuracy in screening for trisomy 21, 18, and 13 early in pregnancy.
Liu, J., et al. (2022). The accuracy and feasibility of noninvasive prenatal testing in a large cohort of pregnancies. Journal of Clinical Laboratory Analysis. Reports high sensitivity and specificity of NIPT for common trisomies across over 20,000 pregnancies, supporting its clinical utility as a screening tool.
Alyafee, S., Al Tuwaijri, A., Alam, N., et al. (2025). Next generation sequencing based non‑invasive prenatal testing: Implementation and outcomes from a regional population. Journal of Genetic Screening. Provides evidence that implementation of high‑throughput sequencing NIPT is feasible and effective, detecting common trisomies with strong performance indicators.

Labeeb & Search Tools

Let us help you

Use Labeeb smart tools to understand reports related to (Medical Laboratories), or search the platform directory directly.

Browse services alphabetically A-Z

LahaLak is here to help

Didn’t find the service?

We can help request the service and prepare your inquiry, or you can ask Labeeb to guide you to the most suitable category or service.

Phone call

Your opinion matters

Was this content helpful?

Have a note?

Important Notice:

Content on LahaLak is provided for educational purposes only. It is not a medical diagnosis, prescription, or substitute for consulting a qualified clinician. Medical decisions should not be made from this content alone.

Content reviewed according to the LahaLak Quality Charter.Editorial Policy & Medical Standards

View service availability

View availability

Medical Laboratories

Non-Invasive Prenatal Test (NIPT)

Non-Invasive Prenatal Testing (NIPT)

A safe and highly accurate blood test to screen for fetal genetic abnormalities early in pregnancy, providing peace of mind for expecting parents from home.

Trusted medical contentUpdated: 25-04-2026Views: 117LHL-10

View service availability

Home Service Available

Service typeLaboratory Test (Blood)

Duration10-15 minutes

Fasting / preparationFasting is not required

Home serviceAvailable

Medical notice: this information is for education and service understanding. It is not a diagnosis or a recommendation for an unnecessary procedure.

About this service

What does it detect?

Down syndrome (Trisomy 21).
Edwards syndrome (Trisomy 18).
Patau syndrome (Trisomy 13).
Some disorders related to the sex chromosomes (X and Y).

Features:

Non-invasive It is done by taking a sample from the mother's blood, making it safer compared to surgical tests.
Accurate Results It is characterized by an accuracy of up to 99% in detecting certain genetic abnormalities, especially Down syndrome.
Done Early It can be performed early in pregnancy, typically starting from the 10th week.

Recommended for:

Women at increased risk of genetic disorders due to age (35 years or older).
Women with a family history of genetic abnormalities.
Women who have had abnormal results in routine pregnancy tests.

Optimal timing:

Typically between the 10th and 13th weeks of pregnancy. It can be performed early in pregnancy to help parents obtain accurate information about the health of the fetus, especially regarding the detection of certain genetic abnormalities like Down syndrome.
This test is done using a simple blood sample from the mother, and it is recommended to be done during this early period to ensure accurate results and provide time for making necessary decisions based on the outcomes.

Preparations:

No special preparation is required. It does not require fasting or any specific preparations before the test.
It is always recommended to consult a specialist doctor before undergoing the test to obtain detailed information and ensure that the test is appropriate for your condition and pregnancy circumstances.

Steps:

Purchase the service by selecting the appropriate provider below. Our medical team will contact you and may ask you to provide the necessary information about the patient's health and the address where the sample will be collected.
Follow-up on the results: After the test is done, the medical team will review and analyze the results.
Sending medical reports: The medical reports will be sent to you.
Consulting with the doctor: Based on the results, the doctor may contact the patient or family to discuss the results and possible medical recommendations.

What is included?

✓Nurse visit for blood sample collection with results provided within 24 hours.
✓The optimal health guidance based on the result.
✓Personal support services from Lahalak

Conditions and notices

Fasting is not required
The terms and conditions announced on the "Lahalak" medical platform apply.
There are no special conditions for the service other than those mentioned.

Frequently Asked Questions

Short answers to the FAQs published with this service.

Is the genetic test safe for the mother and the fetus?

Yes, the non-invasive genetic test is completely safe for both the mother and the fetus. It only requires a blood sample from the mother and does not affect the pregnancy in any way.

When will I get the results?

The results are usually ready within 5 to 10 business days, and they will be sent to you via email or through direct communication.

Can the results be trusted?

The genetic test (NIPT) is highly accurate, with an accuracy rate of up to 99% for detecting certain genetic abnormalities, and it is highly reliable in assessing pregnancy-related risks.

Does the test cover all genetic disorders?

What is the cost of the at-home genetic test?

Is support provided if the results are abnormal?

Yes, we offer full support in case the results are abnormal. Specialized medical consultations will be provided to help you understand the results and take the appropriate steps.

How is the confidentiality of the results maintained?

We adhere to the highest standards of confidentiality. The test results are securely stored and are only sent to you through trusted channels.

Service resources and references

References and additional resources

Reference material and files associated with this service when available.

Scientific references

Bianchi, D. W., Parker, R. L., Wentworth, J., et al. (2014). DNA sequencing versus standard prenatal aneuploidy screening. New England Journal of Medicine, 370(9), 799–808. Landmark study showing that NIPT has higher sensitivity and specificity for detecting common trisomies (e.g., Down, Edwards, Patau) compared with traditional screening.
Norton, M. E., Jacobsson, B., Swamy, G. K., et al. (2015). Cell‑free DNA analysis for noninvasive prenatal screening. New England Journal of Medicine, 372(17), 1589–1597. Demonstrates that NIPT using cell‑free fetal DNA in maternal blood provides high accuracy in screening for trisomy 21, 18, and 13 early in pregnancy.
Liu, J., et al. (2022). The accuracy and feasibility of noninvasive prenatal testing in a large cohort of pregnancies. Journal of Clinical Laboratory Analysis. Reports high sensitivity and specificity of NIPT for common trisomies across over 20,000 pregnancies, supporting its clinical utility as a screening tool.
Alyafee, S., Al Tuwaijri, A., Alam, N., et al. (2025). Next generation sequencing based non‑invasive prenatal testing: Implementation and outcomes from a regional population. Journal of Genetic Screening. Provides evidence that implementation of high‑throughput sequencing NIPT is feasible and effective, detecting common trisomies with strong performance indicators.

Service availability

Choose a provider and branch

Each provider has one service price, then you choose from its available branches.

Labeeb & Search Tools

Let us help you

Use Labeeb smart tools to understand reports related to (Medical Laboratories), or search the platform directory directly.

Browse services alphabetically A-Z

LahaLak is here to help

Didn’t find the service?

We can help request the service and prepare your inquiry, or you can ask Labeeb to guide you to the most suitable category or service.

Phone call

Related services

Services you might also like

Medical service

Genetic Test for Iron Overload

Identify the genetic cause of iron overload through precise SLC40A1 gene sequencing, enabling early diagnosis of ferroportin disease and effective management of your long-term health.

Starting from4,623 SAR

View service

Medical service

Genetic Bone Health Screening

Identify genetic variants linked to bone density and rare hereditary disorders like sclerosteosis, enabling precise diagnosis and better long-term clinical management for you and your family members.

Starting from1,817 SAR

View service

Medical service

Safe Anesthesia Screening Test

Planning for surgery? This test identifies genetic variants affecting anesthesia metabolism, helping prevent prolonged respiratory issues after surgery for a safer and more predictable surgical experience for you.

Starting from230 SAR

View service

Medical service

Advanced Fabry Disease Screening

Accurately measure GL-3 levels to assess Fabry disease, aiding in early diagnosis and monitoring treatment efficacy to protect vital organs like the heart and kidneys.

Starting from684 SAR

View service

Your opinion matters

Was this content helpful?

Have a note?

Important Notice:

Content reviewed according to the LahaLak Quality Charter.Editorial Policy & Medical Standards

View service availability